Akèy › Maladi Parkinson › Washington
Etid klinik pou Maladi Parkinson nan Washington
15 etid pou Maladi Parkinson ap chèche patisipan nan sit nan Washington.
Vil nan Washington
Tèks ofisyèl etid la (Anglè)
A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease
- Site-007, Bellevue
- Site-019, Seattle
Ap rekriteFaz 2/3
Laj 40 a 80 · Tout sèks · Mizajou Sep 28, 2026 · NCT06976268Low-dose Carbon Monoxide (HBI-002) Trial to Evaluate Safety, Tolerability, PK, and Biomarkers in Parkinson's Disease
- Inland Northwest Research, Spokane
Ap rekriteFaz 2
Laj 40 a 80 · Tout sèks · Mizajou Sep 21, 2026 · NCT07005180A Study of Buntanetap in Participants With PD
- Inland Northwest Research, Spokane
Ap rekriteFaz 2/3
Laj 40 a 85 · Tout sèks · Mizajou Sep 21, 2026 · NCT07284784Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry
- Evergreen Health, Kirkland
- Virginia Mason Medical Center, Seattle
- University of Washington Medical Center, Seattle
- ak 1 plis
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Sep 16, 2026 · NCT02071134A Study to Evaluate the Efficacy, PK, Safety, and Tolerability of VIM0423 in Adults With Parkinson's Disease Tremor Insufficiently Responsive to Dopaminergic Therapy
- Vima Site #023, Kirkland
- Vima Site #015, Spokane
Ap rekriteFaz 2
Laj 18 a 65 · Tout sèks · Mizajou Sep 11, 2026 · NCT07804615A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (PD) Participants With Motor Fluctuations
- EvergreenHealth (Site #219), Kirkland
Ap rekriteFaz 2
Laj 30 a 80 · Tout sèks · Mizajou Sep 10, 2026 · NCT07432958Parkinson's Foundation PD GENEration Genetic Registry
- Evergreen Health, Kirkland
- Inland Northwest Research, Spokane
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Sep 8, 2026 · NCT04994015A US Study That Observes How Parkinson's Disease Changes Over Time in Patients Who Still Have Movement Symptoms Despite Taking Parkinson's Medications
- VA Puget Sound Health Care System, Seattle
Ap rekriteEtid obsèvasyon
Laj 45 a 75 · Tout sèks · Mizajou Sep 4, 2026 · NCT07330258A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease
- EvergreenHealth, Kirkland
- Inland Northwest Research, Spokane
Ap rekriteFaz 2
Laj 40 a 80 · Tout sèks · Mizajou Aug 28, 2026 · NCT06680830A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's Disease
- EvergreenHealth - Research Department, Kirkland
Ap rekriteFaz 3
Laj 45 a 75 · Tout sèks · Mizajou Aug 4, 2026 · NCT06944522PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort
- Univ of Washington and VA Puget Sound Health Care System, Seattle
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 30 ak plis · Tout sèks · Mizajou Jul 27, 2026 · NCT04477785Use of CereGate Therapy for Freezing of Gait in PD
- University of Washington, Seattle
Ap rekrite
Laj 21 a 80 · Tout sèks · Mizajou May 28, 2026 · NCT05292794A Study of LY4006896 in Healthy Participants and Participants With Parkinson's Disease
- Evergreen Health Research, Kirkland
- Inland Northwest Research, Spokane
Ap rekriteFaz 1Volontè an sante akeyi
Laj 30 a 85 · Tout sèks · Mizajou Apr 20, 2026 · NCT06809400The Parkinson's Genetic Research Study
- VA Puget Sound Health Care System, Seattle
- University of Washington, Seattle
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou May 14, 2024 · NCT01558479Modifiable Variables in Parkinsonism (MVP)
- Bastyr University, Kenmore
Ap rekriteEtid obsèvasyon
Laj 19 ak plis · Tout sèks · Mizajou Mar 25, 2022 · NCT02194816Sous ClinicalTrials.gov, done yo ranmase Oct 2, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.